#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4767142	F	Adjuvanted-antitumor vaccine activity in C57BL/6 mouse bone marrow derived cells assessed as induction of IL-12 production at 10^-4 to 10^1 ug/ml incubated for 48 hrs by ELISA	Mus musculus	5		cell-based format	Scientific Literature
2.	ALA4767143	F	Adjuvanted-antitumor vaccine activity in C57BL/6 mouse bone marrow derived cells assessed as induction of IL-6 production at 10^-4 to 10^1 ug/ml incubated for 48 hrs by ELISA	Mus musculus	5		cell-based format	Scientific Literature
3.	ALA4767144	F	Adjuvanted-antitumor vaccine activity in C57BL/6 mouse bone marrow derived cells assessed as induction of T cell activation at 10^-4 to 10^1 ug/ml incubated for 48 hrs in presence of mouse OT2-derived CD4+ T cell by ELISA	Mus musculus	2		cell-based format	Scientific Literature
4.	ALA4767145	F	Adjuvanted-antitumor vaccine activity in C57BL/6 mouse assessed as fold increase in OT-2 T cells in spleen at 11.7 nmol, ID coadministered with OT2-derived CD4+ T cell after 5 days by ELISA	Mus musculus	3		organism-based format	Scientific Literature
5.	ALA4767146	F	Adjuvanted-antitumor vaccine activity in C57BL/6 mouse assessed as induction of OT2-T cell mediated IFNgamma production in lymph node at 11.7 nmol, ID incubated for 5 days by anti-IFNgamma staining based flow cytometry	Mus musculus	2		organism-based format	Scientific Literature
6.	ALA4767147	F	Adjuvanted-antitumor vaccine activity in C57BL/6 mouse assessed as induction of OT2-T cell mediated IFNgamma production in splenocytes at 11.7 nmol, ID followed by stimulation with OVA(323 to 339) peptide after 48 hrs by ELISA	Mus musculus	2		organism-based format	Scientific Literature
7.	ALA4767148	F	Adjuvanted-antitumor vaccine activity in C57BL/6 mouse assessed as induction of OT2-T cell mediated IL-5 production in splenocytes at 11.7 nmol, ID followed by stimulation with OVA(323 to 339) peptide incubated for 48 hrs by ELISA	Mus musculus	2		organism-based format	Scientific Literature
8.	ALA4767150	F	Immuno-adjuvant activity in C57BL/6 mouse assessed as antibody response to Tn3G7K by measuring serum IgG levels at 11 .7 nmol, ID at day 0 and day 21 and measured post second dose	Mus musculus	2		organism-based format	Scientific Literature
9.	ALA4767151	F	Immuno-adjuvant activity in C57BL/6 mouse assessed as antibody response to (2R,8R,11S,14R,20R)-14-(2-amino-2-oxoethyl)-20-((2S,5R,8S,11R,14S,17R,20S,23R,26S)-5,14-bis((1H-imidazol-5-yl)methyl)-36-(4-(22-(4-((6-amino-2-(2-methoxyethoxy)-8-oxo-7H-purin-9(8H)-yl)methyl)phenyl)-3,7,11,15,22-pentaoxo-6-(3-((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)propyl)-10,14-bis(3-((2S,3S,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)propyl)-2,6,10,14,21-pentaazadocosyl)-1H-1,2,3-triazol-1-yl)-23-(3-amino-3-oxopropyl)-29-sec-butyl-26-(hydroxymethyl)-17-isopropyl-2,8,11,20-tetramethyl-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazahexatriacontanamido)-17-sec-butyl-11-(2-carboxyethyl)-2-(3-guanidinopropyl)-8-methyl-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazatricosane-1,23-dioic acid by measuring serum IgG levels at 11 .7 nmol, ID at day 0 and day 21 and measured post second dose	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA4767152	F	Immuno-adjuvant activity in immunized-C57BL/6 mouse assessed as antibody recognition in sera against 21 at 11 .7 nmol, ID at day 1 and day 20 and measured post second dose on day 27	Mus musculus	2		organism-based format	Scientific Literature
11.	ALA4767153	F	Immuno-adjuvant activity in immunized-C57BL/6 mouse assessed as antibody recognition in sera against 22 at 11 .7 nmol, ID at day 1 and day 20 and measured post second dose on day 27	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA4767154	F	Immuno-adjuvant activity in immunized-C57BL/6 mouse assessed as antibody recognition in sera against Tn3G7K at 11 .7 nmol, ID at day 1 and day 20 and measured post second dose on day 27	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA4767156	F	Immuno-adjuvant activity in C57BL/6 mouse assessed as antibody response to OVA peptide by measuring serum IgG levels at 11 .7 nmol, ID at day 0 and day 21 and measured post second dose	Mus musculus	2		organism-based format	Scientific Literature